Julio Chavez, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Kite
    Topic:
    Consulting
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Novartis
    Topic:
    Consulting
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    BMS/Celgene
    Topic:
    Consulting
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    GenMab
    Topic:
    Consulting
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research support
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Jannsen
    Topic:
    Research Support
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Research Support
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Allogene
    Topic:
    Consulting
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Beigene
    Topic:
    Honoraria
    Date added:
    01/22/2024
    Date updated:
    01/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Lilly
    Topic:
    Honoraria
    Date added:
    01/22/2024
    Date updated:
    01/22/2024

Pages

Return to Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting